The NTLEP Program Manager, Dr. Kuzani Mbendera, has commended the media for its crucial role in combating tuberculosis (TB) and leprosy in Malawi.
Speaking at the World TB and Leprosy Day commemoration in Mgona, Lilongwe, Mbendera emphasized that Malawi remains committed to fighting these diseases nationwide. He highlighted the program’s continued reliance on trained journalists to combat misinformation and spread accurate health information.
“Madam First Lady, for over five years, we have been training journalists from across the country on TB and leprosy issues to curb misinformation and stigma,” said Mbendera. He further announced that biannual meetings would resume to update the media and faith community on the latest developments in TB and leprosy.
First Lady Monica Chakwera, the event’s guest of honor, also acknowledged the media’s role, stating that the battle against TB and leprosy cannot be won without the “fourth estate.”
In 2024, Malawi recorded 18,310 TB cases, with 18,000 patients on treatment—a significant decline from the previous year. The TB treatment success rate slightly improved to 91% from 90% in 2023, while the mortality rate dropped from 7% to 6%. For leprosy, 364 new cases were identified in 2024, bringing the total number of patients on treatment to 665.
“This double commemoration reminds us of the urgent need to raise awareness, confront stigma, and accelerate efforts to eliminate TB and leprosy,” said the First Lady.
Minister of Health Khumbize Kandodo Chiponda reaffirmed the government’s commitment to eradicating TB and leprosy, calling for stronger collaboration among the government, partners, and communities.
“We must increase investment in research, new diagnostic technologies, and treatment, which are critical to ending TB and leprosy,” said Chiponda. She also praised Malawi’s health workers for their dedication to fighting these diseases.
This year’s World TB and Leprosy Day is themed “Yes! We Can End TB—Commit, Invest, Deliver” and “Unite, Act, Eliminate TB and Leprosy.” Malawi aims to eliminate TB and leprosy by 2030.
